Status:
ACTIVE_NOT_RECRUITING
Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive Gastrectomy
Lead Sponsor:
Fujian Medical University
Conditions:
Gastric Adenocarcinoma
Surgery, Laparoscopic
Eligibility:
All Genders
Brief Summary
The Benchmark-MISGC study was a large-scale retrospective observational study launched by the China Gastric Cancer Surgical Union, aiming to establish the benchmarks of the short- and long-term outcom...
Eligibility Criteria
Inclusion
- Patients with postoperative histologically confirmed gastric adenocarcinoma at stages T1-4a, N0/+, M0;
- underwent robotic or laparoscopic gastrectomies with curative intent
Exclusion
- ASA class \> 3;
- remnant gastric cancer;
- concurrent/previous malignant disease;
- Distant metastasis;
- Palliative resection;
- Abodominal exploration.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
90000 Patients enrolled
Trial Details
Trial ID
NCT06938139
Start Date
March 1 2025
End Date
April 30 2025
Last Update
April 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fujian medical university union hospital
Fuzhou, Fujian, China, 350000